Safety and tolerance of Lactobacillus reuteri supplementation to a population infected with the human immunodeficiency virus.
- 1998-12
- RCT · n = 39
- Food and Chemical Toxicology 36(12)
- B. W. Wolf
- K. Wheeler
- D. G. Ataya
- K. Garleb
- PubMed: 9862651
- DOI: 10.1016/S0278-6915(98)00090-8
- High evidence
- Highly Cited
Consumption of L. reuteri tended to increase faecal levels of L. reuteri on days 7, 14 and 21 of treatment feeding (P < 0.06, P < 0.11 and P = 0.05, respectively).
- Effect
- Neutral
- Effect size
- Small
- Significant
- No